Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Immunogenicity in Adolescents Previously Vaccinated with Pandemrix
NCT01190215Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluarix in influenza, sponsored by GSK. Started Oct 2010; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01190215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190215.